Epstein Secrets

e Genetics $200,000 Cold-resistant elephants $2,500,000 2nd tranche $10,000,000 Total 1) Thirty genomes collected so far on a small budget by James Clement. $200K would get 8% ownership of the company and allow another 30 genomes to be collected, sequenced and therapies patented. 2) Using CRISPR to e

r animals for resistance to infectious diseases and to act as transplantation donors for major organs (initially kidneys) to humans. Co-founded with Prashant Mali and Luhan Yang. Already has a couple of contracts and a some rented lab space. 3) Sensor-selector technology for optimizing commercial production o

d-resistant elephants $2,500,000 2nd tranchc $10,000,000 Total 1) Supercentenarianstudv.com Thirty genomes collected so far on a small budget by James Clement. $200K would get 8% ownership of the company and allow another 30 genomes to be collected, sequenced and therapies patented. 2) eGenesisBio.com: U

r animals for resistance to infectious diseases and to act as transplantation donors for major organs (initially kidneys) to humans. Co-founded with Prashant Mali and Luhan Yang. Already has a couple of contracts and a some rented lab space. 3) Sensor-selector technology for optimizing commercial production o

netics Cold-resistant elephants 2nd tranche $10,000,000 Total I ) Supercentenarianstudv.com Thirty genomes collected so far on a small budget by James Clement. $200K would get 8% ownership of the company and allow another 30 genomes to be collected, sequenced and therapies patented. 2) eGenesisBio.com: U

r animals for resistance to infectious diseases and to act as transplantation donors for major organs (initially kidneys) to humans. Co-founded with Prashant Mali and EFTA_R1_00488322 EFTA01980272 Luhan Yang. Already has a couple of contracts and a some rented lab space. 3) Sensor-selector technology for o

logy Space Genetics Cold-resistant elephants 2nd tranche Total 1) Supercentenarianstudv.com Thirty genomes collected so far on a small budget by James Clement. $200K would get 8% ownership of the company and allow another 30 genomes to be collected, sequenced and therapies patented. 2) eGenesisBio.com: U

r animals for resistance to infectious diseases and to act as transplantation donors for major organs (initially kidneys) to humans. Co-founded with Prashant Mali and Luhan Yang. Already has a couple of contracts and a some rented lab space. 3) Sensor-selector technology for optimizing commercial production o